TherapeuticsMD
TXMD
TXMD
158 hedge funds and large institutions have $195M invested in TherapeuticsMD in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 45 increasing their positions, 39 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
158
Holders Change
+17
Holders Change %
+12.06%
% of All Funds
2.8%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
29
Increased
45
Reduced
39
Closed
12
Calls
$1.17M
Puts
$1.27M
Net Calls
-$99K
Net Calls Change
-$470K
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$11.1M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$9.45M |
| 3 |
LCM
Laurion Capital Management
New York
|
+$4.01M |
| 4 |
BlackRock
New York
|
+$3.3M |
| 5 |
Axa
Paris,
France
|
+$1.34M |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
-$15.1M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$11.4M |
| 3 |
IM
Islet Management
New York
|
-$2.37M |
| 4 |
CC
Clearline Capital
New York
|
-$1.15M |
| 5 |
Goldman Sachs
New York
|
-$1.14M |
